Articles about Oxford University

Mattel, the maker of the Barbie doll, has created a doll to honor Professor Sarah Gilbert, who led the development of the Oxford University and AstraZeneca COVID-19 vaccine.

A single dose of AstraZeneca's COVID-19 vaccine results in an 80% less risk of death from the viral infection, Public Health England (PHE), the executive agency of the UK department of health, said on Monday, citing data from the vaccine's rollout.

Weighing in on the Oxford University racism row, External Affairs Minister, S Jaishankar, on Monday said India will take up the matter with the UK when required. He was responding to BJP MP Ashwini Vaishnaw's query in the Parliament.

The Maharashtra government has ordered a probe into the fire that broke out at the Serum Institute of India in Pune on Thursday, killing at least five people.

Maldives is set to become the first foreign country to receive COVID-19 vaccines from India. The Asian country will reportedly receive a consignment of Covishield doses on Wednesday.

On Saturday, India launched its COVID-19 vaccination drive, inoculating 1.91 lakh people on the first day alone.

The Delhi government has identified 89 sites for the COVID-19 vaccination drive in the national capital, Health Minister Satyendar Jain said on Sunday.

India is looking forward to launching a massive COVID-19 vaccination drive with two vaccines that have been granted emergency use authorization (EUA).

The central government has prepared a detailed draft for the transport of vaccines across India ahead of a nationwide roll-out.

A dry run of the COVID-19 vaccine roll-out was conducted in Haryana on Thursday, a day before the exercise will be conducted across India.

The Serum Institute of India (SII) and Bharat Biotech have taken a joint pledge to ensure global access of the COVID-19 vaccines developed by them.

Hyderabad-based pharmaceutical company Bharat Biotech has been allowed to conduct clinical trials for its COVID-19 vaccine on children above the age of 12.

Serum Institute of India's (SII) chief Adar Poonawalla today wished everyone a happy new year along with a great announcement.

Earlier on Sunday, the Drugs Controller General of India (DCGI) announced the issuance of emergency approval to two COVID-19 vaccines for restricted use in India: Covishield and COVAXIN.

Two COVID-19 vaccines, Covishield and COVAXIN, have been granted emergency approval for use in India, the Drugs Controller General of India (DCGI) Dr. VG Somani said on Sunday.

A government-appointed panel on Saturday recommended emergency-use authorization (EUA) to the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech.

The United Kingdom on Wednesday approved the vaccine developed by Oxford University and the British-Swedish pharmaceutical company AstraZeneca, giving the vaccine an endorsement that will likely be considered by Indian drug regulators.

The COVID-19 vaccine developed by Oxford University and AstraZeneca has been approved for use in the United Kingdom.

The Ministry of Home Affairs on Monday extended guidelines for COVID-19 surveillance, containment, and caution till January 31, 2021.

The coronavirus vaccine developed by Oxford University and AstraZeneca should be effective against the highly transmissible new strain of the virus, a UK media report said on Sunday.

Labeled as a coronavirus hotspot once, Dharavi, believed to be the largest slum in Asia, reported no new coronavirus cases on Friday since April 1 when the first infection came to light.

Developers of the Russian coronavirus vaccine Sputnik V on Monday announced signing an agreement with AstraZeneca to test a combination of the British drug maker's COVID-19 shots and a component of the vaccine created in Moscow.

India will reportedly produce around 300 million doses of the Russian COVID-19 vaccine called Sputnik V.

The University of Oxford and pharmaceutical firm AstraZeneca became the first coronavirus vaccine developers to release their final-stage clinical trial data.

India may license some COVID-19 vaccines in the next few weeks, the Union Health Ministry said on Tuesday.

A 90-year-old woman in the United Kingdom has become the world's first person to receive the COVID-19 vaccine developed by Pfizer and BioNTech outside of clinical trials.

With the coronavirus vaccine trials being conducted by Serum Institute of India (SII) being shrouded in controversy after a participant complained of an "adverse reaction," the Centre on Tuesday said there's no need to stop the process.

The Serum Institute of India (SII) on Tuesday said that its COVID-19 vaccine candidate was "safe and immunogenic," in response to allegations that a trial participant developed serious side-effects after being administered the dose.

The Serum Institute of India (SII) has said that it will seek Rs. 100 crore in damages from a COVID-19 vaccine trial participant for complaining about side-effects.

The CEO of the Serum Institute of India (SII), Adar Poonawalla, on Saturday said that the company will seek the emergency-use authorization of the coronavirus vaccine 'Covishield' soon.

Prime Minister Narendra Modi will visit three cities today to review the coronavirus vaccine development and manufacturing process, his office revealed.

The Russian vaccine for COVID-19, called Sputnik V, has been found at least 91% effective in the second interim analysis.

The CEO of the Serum Institute of India (SII), Adar Poonawalla, has said that the institute can roll out 100 million doses of the COVID-19 vaccine by January-February.

The coronavirus vaccine being developed by Oxford University and British pharma giant AstraZeneca is 70% effective, results from large-scale trials have shown, multiple reports said on Monday.

Pune-based Serum Institute of India, which has partnered with Oxford University and British pharma giant AstraZeneca, plans to seek an emergency approval from the government of India next month, for providing the coronavirus vaccine to "corona warriors" and the elderly.

India's Health Minister Dr. Harsh Vardhan said today that deliveries of coronavirus vaccine will happen within a few months, adding that the country's scientists are way ahead in terms of research.

American biotech company Moderna Therapeutics has announced that its COVID-19 vaccine was found to be nearly 95% effective in preventing the novel coronavirus disease.

It has been a great rewind for the fans of Claire Foy, the actor who played the role of Queen Elizabeth II in the first two seasons of Netflix British empire drama The Crown.

The Serum Institute of India is hoping to produce 100 million (10 crore) doses of AstraZeneca and Oxford University's COVID-19 vaccine, CEO Adar Poonawalla said.

The Indian Council of Medical Research (ICMR) and Pune-based Serum Institute of India (SII) on Thursday announced the completion of enrollment of participants to the Phase-3 clinical trials for the potential COVID-19 vaccine COVISHIELD in India.